Q4 2025 Vivos Therapeutics Inc Earnings Call Transcript
Key Points
- Vivos Therapeutics Inc (VVOS) reported a 16% increase in full-year 2025 revenue, primarily driven by the acquisition of Sleep Center of Nevada (SCN) and increased sleep testing services.
- The company achieved a 17% increase in gross profit for the full year 2025 compared to 2024, maintaining a consistent gross margin of 60%.
- Vivos Therapeutics Inc (VVOS) has successfully integrated SCN, leading to increased patient demand for their OSA treatment options, which are seen as preferable alternatives to CPAP.
- The company has secured in-network status with several commercial health insurance payers and Medicare, enhancing patient access to their treatments.
- Vivos Therapeutics Inc (VVOS) is expanding its Sleep Optimization (SO) teams, which are expected to generate significant revenue and improve patient outcomes.
- The company experienced a decrease in product revenue from legacy VIP dentists, with a decline of approximately $1.4 million in appliance and tooth positioner sales.
- Operating expenses increased significantly to $30.4 million for the full year 2025, primarily due to higher general and administrative expenses related to the new business model.
- Vivos Therapeutics Inc (VVOS) reported a net loss of $21.2 million for 2025, reflecting higher costs associated with the strategic transition.
- The company faced challenges in Q4 2025 due to insufficient numbers of providers, leading to a decline in revenue compared to Q3.
- Vivos Therapeutics Inc (VVOS) has a high level of total liabilities, increasing to approximately $26.7 million as of December 31, 2025, due to debt incurred for the SCN acquisition.
Good day, everyone, and welcome to the Vivo's full-year 2025 earnings conference call. (Operator Instructions) This conference call is being recorded, and a replay of today's call will be available on the Investor Relations section of Vivos' website and will remain posted there for the next 30 days.
I will now hand the call over to Brad Amman, Chief Financial Officer for introductions and a reading of the Safe Harbor Statement. Please go ahead.
Thank you, operator. Hello, everyone, and welcome to our 2025 conference call. A copy of our earnings press release is available on the Investor Relations section of our website at www.vivos.com.
With me on the call today is Kirk Huntsman, Vivos Chairman and Chief Executive Officer. Today, we will review the financial results for the full year 2025 as well as more recent developments and Vivos' plans for 2026 and beyond. Following these formal remarks, we will be happy to take
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
